Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 844 | 836 | 809 | 861 | 957 | 943 | 931 | 1,031 | 1,099 | 1,121 | 1,159 | 1,304 |
| Expenses | 631 | 620 | 629 | 675 | 728 | 706 | 707 | 784 | 868 | 904 | 915 | 1,017 |
| Operating Profit | 213 | 216 | 179 | 186 | 228 | 238 | 225 | 247 | 231 | 217 | 244 | 287 |
| OPM % | 25% | 26% | 22% | 22% | 24% | 25% | 24% | 24% | 21% | 19% | 21% | 22% |
| Other Income | 21 | 18 | 27 | 22 | 18 | 16 | -27 | 20 | 36 | -15 | 37 | 22 |
| Interest | 20 | 18 | 18 | 18 | 16 | 16 | 15 | 14 | 17 | 22 | 27 | 27 |
| Depreciation | 43 | 44 | 45 | 47 | 49 | 48 | 49 | 45 | 50 | 61 | 67 | 69 |
| Profit before tax | 171 | 172 | 143 | 144 | 181 | 189 | 133 | 208 | 200 | 120 | 187 | 213 |
| Tax % | 27% | 28% | 11% | 26% | 28% | 24% | 24% | 24% | 21% | 21% | 24% | 26% |
| Net Profit | 125 | 124 | 127 | 106 | 131 | 143 | 101 | 159 | 158 | 95 | 142 | 157 |
| EPS in Rs | 4.66 | 4.61 | 4.74 | 3.96 | 4.87 | 5.32 | 3.78 | 5.92 | 5.89 | 3.54 | 5.36 | 5.90 |
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,382 | 1,343 | 1,456 | 1,500 | 1,447 | 2,167 | 2,710 | 3,275 | 3,692 | 4,410 | 4,683 |
| Expenses | 1,081 | 1,218 | 1,283 | 1,309 | 1,250 | 1,709 | 2,073 | 2,466 | 2,806 | 3,480 | 3,705 |
| Operating Profit | 301 | 125 | 172 | 192 | 197 | 458 | 637 | 809 | 886 | 930 | 979 |
| OPM % | 22% | 9% | 12% | 13% | 14% | 21% | 24% | 25% | 24% | 21% | 21% |
| Other Income | 45 | 49 | 50 | 44 | 31 | 39 | 49 | 75 | 29 | 98 | 80 |
| Interest | 14 | 28 | 38 | 57 | 73 | 86 | 86 | 84 | 74 | 90 | 92 |
| Depreciation | 70 | 86 | 102 | 115 | 123 | 130 | 150 | 173 | 194 | 223 | 246 |
| Profit before tax | 262 | 60 | 83 | 64 | 32 | 281 | 449 | 627 | 647 | 715 | 720 |
| Tax % | 35% | 45% | 38% | 43% | 11% | 30% | 27% | 24% | 26% | 23% | |
| Net Profit | 170 | 33 | 51 | 36 | 29 | 196 | 326 | 478 | 481 | 554 | 552 |
| EPS in Rs | 35.10 | 6.78 | 10.44 | 7.36 | 5.81 | 7.75 | 12.16 | 17.81 | 17.92 | 20.70 | 20.69 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 2% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 12% | 25% | 18% | 21% | ||
| Compounded Profit Growth | 13% | 81% | 19% | 0% | ||
| Stock Price CAGR | % | % | 25% | 8% | ||
| Return on Equity | % | 16% | 16% | 15% |
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 48 | 48 | 49 | 49 | 50 | 51 | 54 | 54 | 54 | 54 |
| Reserves | 976 | 1,136 | 1,246 | 1,300 | 1,333 | 1,565 | 2,375 | 2,852 | 3,333 | 3,908 |
| Borrowings | 165 | 456 | 787 | 929 | 931 | 1,109 | 1,122 | 802 | 718 | 1,190 |
| Other Liabilities | 295 | 343 | 347 | 388 | 380 | 421 | 547 | 572 | 662 | 753 |
| Total Liabilities | 1,485 | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,097 | 4,280 | 4,766 | 5,905 |
| Fixed Assets | 914 | 1,094 | 1,194 | 1,703 | 1,616 | 1,776 | 2,050 | 2,236 | 2,514 | 3,795 |
| CWIP | 12 | 317 | 666 | 382 | 464 | 439 | 327 | 388 | 533 | 132 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
| Other Assets | 559 | 573 | 570 | 581 | 615 | 930 | 1,720 | 1,656 | 1,716 | 1,975 |
| Total Assets | 1,485 | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,097 | 4,280 | 4,766 | 5,905 |
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 228 | 63 | 166 | 175 | 242 | 311 | 645 | 612 | 624 | 714 |
| Cash from Investing Activity | -241 | -69 | -249 | -87 | -239 | -421 | -342 | -441 | -721 | -1,089 |
| Cash from Financing Activity | -7 | 9 | 97 | -1 | -81 | 160 | 346 | -514 | -97 | 272 |
| Net Cash Flow | -20 | 3 | 14 | 87 | -78 | 50 | 648 | -343 | -194 | -103 |
| Free Cash Flow | 71 | -81 | -133 | -13 | 100 | 38 | 409 | 335 | 110 | -123 |
| CFO/OP | 108% | 93% | 135% | 121% | 131% | 89% | 118% | 98% | 89% | 90% |
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 41 | 41 | 36 | 34 | 30 | 26 | 24 | 29 | 34 |
| Inventory Days | 28 | 26 | 26 | 43 | 42 | 36 | 35 | 32 | 28 | 29 |
| Days Payable | 92 | 124 | 142 | 147 | 138 | 90 | 114 | 90 | 81 | 89 |
| Cash Conversion Cycle | -45 | -56 | -75 | -67 | -62 | -24 | -52 | -34 | -24 | -26 |
| Working Capital Days | -23 | -33 | -18 | -31 | -48 | -20 | -37 | -32 | -21 | -7 |
| ROCE % | 6% | 6% | 5% | 15% | 17% | 20% | 20% | 17% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 33.06% | 33.05% | 33.04% | 33.04% | 33.04% | 33.03% | 33.03% | 33.01% | 33.01% | 33.01% | 33.01% | 33.00% |
| FIIs | 10.69% | 11.36% | 12.10% | 12.94% | 12.21% | 12.48% | 11.76% | 11.54% | 11.41% | 10.54% | 10.15% | 9.46% |
| DIIs | 10.93% | 11.15% | 10.25% | 10.57% | 11.11% | 10.51% | 11.93% | 12.20% | 12.97% | 13.99% | 14.76% | 16.89% |
| Public | 45.31% | 44.45% | 44.60% | 43.44% | 43.64% | 43.98% | 43.28% | 43.19% | 42.56% | 42.41% | 42.01% | 40.55% |
| Others | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.06% | 0.06% | 0.06% | 0.08% | 0.09% |
| No. of Shareholders | 1,16,627 | 1,24,775 | 1,66,253 | 1,55,307 | 1,49,722 | 1,48,633 | 1,54,688 | 1,56,372 | 1,55,806 | 1,51,241 | 1,47,390 | 1,40,531 |
Fundamentals
Market Cap₹ 38,048 Cr.
Current Price₹ 1,415
Stock P/E66.4
Book Value₹ 147
ROCE17.4 %
ROE15.2 %
Dividend Yield0.04 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)21%
Compounded Profit Growth (TTM)0%
Consolidated figures.
Valuation
Market capRs 36,469 Cr
Enterprise valueRs 36,529 Cr
P/E (TTM)65.57x
Price to book9.21x
Price to sales7.79x
EV / EBITDA34.51x
EV / EBIT44.98x
EV / sales7.80x
Price to cash flow51.05x
Earnings yield1.53%
Dividend yield0.04%
P/E, 3-year average62.48x
P/B, 3-year average9.41x
P/E, 5-year average57.70x
P/B, 5-year average8.51x
Profitability
Operating margin (excl. other income)21.09%
Operating margin (incl. other income)23.30%
EBITDA margin22.60%
Pre-tax margin15.38%
Net profit margin11.88%
Net margin, latest quarter12.17%
ROE15.15%
ROCE17.40%
ROA10.43%
ROE, 3-year average16.13%
ROCE, 3-year average18.49%
ROA, 3-year average10.83%
ROE, 5-year average15.52%
ROCE, 5-year average17.42%
ROA, 5-year average9.64%
ROIC (approx.)15.65%
Tax rate22.51%
Other income / net worth2.46%
Growth
Sales growth (latest year)19.44%
Profit growth (latest year)15.58%
Sales CAGR, 3 years17.63%
Sales CAGR, 5 years24.97%
Profit CAGR, 3 years19.50%
Profit CAGR, 5 years80.79%
Sales growth QoQ12.51%
Profit growth QoQ10.24%
Sales growth YoY (latest quarter)26.50%
Profit growth YoY (latest quarter)-0.18%
Per share
EPS (TTM)Rs 20.70
EPS (latest year)Rs 20.71
EPS (latest quarter)Rs 5.91
EPS, 3-year averageRs 18.81
EPS, 5-year averageRs 15.27
Book value per shareRs 147.44
Sales per shareRs 174.31
Cash flow per shareRs 26.59
Free cash flow per shareRs -4.58
Dividend per share (latest year)Rs 0.50
Dividend per share, 3-year averageRs 0.50
Dividend per share, 5-year averageRs 0.50
Dividends
Dividend payout2.42%
Dividend payout, 3-year average2.42%
Dividend payout, 5-year average2.42%
Efficiency
Asset turnover0.75x
Fixed asset turnover1.16x
Inventory turnover14.73x
Inventory days25 days
Debtor days34 days
Debtors turnover10.73x
Creditor days89 days
Cash conversion cycle-26 days
Working capital days-7 days
Leverage
Total debtRs 1,190 Cr
Cash and bankRs 1,130 Cr
Net debtRs 60 Cr
Debt to equity0.30x
Net debt / EBITDA0.06x
Interest coverage8.83x
Current ratio (filing 2026-03-31)2.67x
Quick ratio (filing 2026-03-31)2.54x
Trade payables (filing 2026-03-31)Rs 242 Cr
Owners' fund to total sources67.09%
Debt to assets20.15%
Cash flow
Cash from Operating Activity (latest year)Rs 714 Cr
Cash from Investing Activity (latest year)Rs -1,089 Cr
Cash from Financing Activity (latest year)Rs 272 Cr
Net Cash Flow (latest year)Rs -103 Cr
Free cash flow (latest year)Rs -123 Cr
FCFE (approx.: FCF + change in debt)Rs 349 Cr
Cash from ops / profit, 5 years1.43x
Sales to cash flow6.17x
Statement figures
Net sales (TTM)Rs 4,683 Cr
Net sales (latest year)Rs 4,410 Cr
Sales (latest quarter)Rs 1,304 Cr
Operating profit excl. other income (latest year)Rs 930 Cr
Operating profit (latest quarter)Rs 287 Cr
Other income (TTM)Rs 80 Cr
EBITDA (TTM)Rs 1,059 Cr
PBDT (TTM)Rs 967 Cr
Profit before tax (TTM)Rs 720 Cr
Tax (latest year)Rs 161 Cr
Net profit (TTM)Rs 556 Cr
Net profit (latest year)Rs 556 Cr
Net profit (latest quarter)Rs 159 Cr
Depreciation (TTM)Rs 246 Cr
Depreciation (latest quarter)Rs 69 Cr
Interest (TTM)Rs 92 Cr
Cost of goods sold (latest year)Rs 1,164 Cr
Total expenditure (latest year)Rs 3,480 Cr
Total income (latest year)Rs 4,508 Cr
Share capitalRs 54 Cr
ReservesRs 3,908 Cr
Shareholders' fundsRs 3,962 Cr
Total assetsRs 5,905 Cr
Net blockRs 3,795 Cr
Capital work in progressRs 132 Cr
InvestmentsRs 3 Cr
ReceivablesRs 411 Cr
InventoryRs 79 Cr
Other liabilitiesRs 753 Cr
Shares outstanding (crore)26.87
Ownership
Promoter holding33.00% (-0.01 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 65.6 is at the 54th percentile of its own 4.0-year range
(median 63.8, low 50.2, high 119.1).
P/B 9.21 is at the 35th percentile (median 9.61).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | MEDANTA | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -9.9% | -2.8% | -7.1 pts |
| 1 month | -6.9% | -6.8% | -0.1 pts |
| 3 months | +0.5% | -7.6% | +8.1 pts |
| 6 months | +41.2% | +0.4% | +40.8 pts |
| 1 year | +2.2% | -9.9% | +12.1 pts |
| 2 years | +23.8% | -13.6% | +37.4 pts |
| 3 years | +89.6% | +14.2% | +75.4 pts |
130 mutual fund schemes hold about ₹6,387 Cr.
Over three months 93 bought more and 20 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Kotak Mid Cap Fund | 1.84% | 1,314 | +6% |
| Invesco India Midcap Fund | 4.26% | 677 | -3% |
| UTI Flexi Cap Fund | 2.06% | 499 | +4% |
| Invesco India Smallcap Fund | 2.06% | 325 | -5% |
| Invesco India Contra Fund | 1.51% | 311 | +9% |
| Canara Rob Small Cap Fund | 1.72% | 252 | +13% |
| Invesco India Focused Fund | 3.83% | 247 | +1% |
| Canara Rob Large and Mid Cap Fund | 0.92% | 243 | -5% |
| Invesco India Large & Mid Cap Fund | 2.04% | 239 | +1% |
| HDFC Multi Cap Fund | 0.81% | 166 | +17% |
| UTI Mid Cap Fund | 1.16% | 148 | +9% |
| Canara Rob Mid Cap Fund | 2.65% | 139 | +4% |
| HDFC Value Fund | 1.54% | 127 | +3% |
| SBI Healthcare Opp Fund | 1.92% | 111 | +29% |
| HDFC Pharma and Healthcare Fund | 2.85% | 94 | -8% |
| Kotak Contra Fund | 1.65% | 91 | +8% |
| Axis Midcap Fund | 0.25% | 85 | +100% |
| Franklin India Multi Cap Fund | 1.57% | 83 | -41% |
| Invesco India Flexi Cap Fund | 1.37% | 78 | -8% |
| HSBC Flexi Cap Fund | 1.12% | 67 | +5% |
| Axis Multicap Fund | 0.58% | 64 | +100% |
| HSBC Consumption Fund | 3.13% | 57 | +5% |
| UTI Focused Fund | 1.93% | 48 | +9% |
| Invesco India Multicap Fund | 1.03% | 47 | -46% |
| Bandhan Focused Fund | 2.16% | 45 | +100% |
Red flags
F-score 4 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹1,304 Cr +26.5% vs Jun 2025.
Net profit ₹157 Cr -1.3%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
| Artemis Medicare Services Ltd | 5,818 | 50.4 | 14.5 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-08-14 | Dividend - Re 0.50 Per Share | |
| 2025-08-22 | Dividend - Re 0.50 Per Share |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)
Quick answers
What is the market cap of Global Health Ltd?
Global Health Ltd (MEDANTA) has a market capitalisation of Rs 38,048 Cr. at the 2026-10-01 close.
What is the P/E ratio of Global Health Ltd?
Global Health Ltd trades at a P/E of 66.4 on trailing twelve-month profit, at the 2026-10-01 close.
What were Global Health Ltd's latest quarterly results?
In the Jun 2026 quarter, Global Health Ltd sales was Rs 1,304 Cr (+26.5% vs Jun 2025) and net profit was Rs 157 Cr.
What is the 52-week high and low of Global Health Ltd?
The 52-week high is Rs 1,544.00 and the 52-week low is Rs 956.00.